In a White House Press Briefing on Thursday, White House Press Secretary Josh Earnest said some pharmaceutical companies have been innovators committed to advancing public health, and others have jacked up the prices of life-saving medicine — a poor business model, which takes a toll on the business' reputation and stock prices. The White House
In a White House Press Briefing on Thursday, White House Press Secretary Josh Earnest said some pharmaceutical companies have been innovators committed to advancing public health, and others have jacked up the prices of life-saving medicine — a poor business model, which takes a toll on the business' reputation and stock prices. The White House

Editorials

Skyrocketing price of EpiPens deserves scrutiny of Congress

August 24, 2016 5:08 PM

  Comments  

Videos